2 min read · 12 October 2009
GI Partners has closed its third fund with $1.9 billion in capital commitments. Limited partners include Florida Retirement System Trust Fund, Teachers’ Retirement System of Illinois, Capital Dynamics and Partners Group.
2 min read · 12 October 2009
2 min read · 12 October 2009
Onyx Pharmaceuticals Inc. (Nasdaq: ONXX) has agreed to acquire Proteolix Inc., a South San Francisco-based drug company focused on protein degradation pathways in cancer and autoimmune diseases. The deal is valued at up to $851 million, including a $276 million up-front cash payment and the remainder in earn-outs. Proteolix has raised around $142 million in VC funding, from firms like U.S. Venture Partners, Advanced Technology Ventures, Latterell Venture Partners, Delphi Ventures, The Vertical Group, Nomura Phase4 Ventures and Westfield Capital Management.
5 min read · 12 October 2009
JO Hambro Capital Management has acquired Celsis International, a Chicago-based contract research firm for the global life sciences market. The deal was valued at approximately £55 million, and will result in Celsis de-listing from the London Stock Exchange.
2 min read · 12 October 2009
GF Capital and Stockton Road Capital have acquired Airborne Inc., a Minneapolis-based maker of dietary supplements for bolstering the immune system. No financial terms were disclosed. Sawaya Segalas & Co. advised Airborne on the sale.
3 min read · 12 October 2009
2 min read · 12 October 2009
2 min read · 12 October 2009
1 min read · 10 October 2009
1 min read · 09 October 2009
